George W J Harston Yee Kai Tee Melanie Jones Stephen Payne George Pope Fintan Sheerin James Kennedy
10.1159/000355144
Cerebrovasc Dis
2013;36(4):324-5.
CC BY
https://pubmed.ncbi.nlm.nih.gov/24193034/
Cerebral Hemorrhage / chemically induced Fibrinolytic Agents / adverse effects Stroke / drug therapy Thrombolytic Therapy / adverse effects Tissue Plasminogen Activator / adverse effects
Cerebral Hemorrhage / chemically induced Fibrinolytic Agents / adverse effects Stroke / drug therapy Thrombolytic Therapy / adverse effects Tissue Plasminogen Activator / adverse effects Case Reports Research Support, Non-U.S. Gov't Video-Audio Media Administration, Intravenous Aged Cerebral Hemorrhage / diagnosis Cerebral Hemorrhage / therapy Diffusion Magnetic Resonance Imaging Disease Progression Fatal Outcome Female Fibrinolytic Agents / administration & dosage Humans Palliative Care Stroke / diagnosis Time Factors Tissue Plasminogen Activator / administration & dosage Treatment Outcome Fibrinolytic Agents Tissue Plasminogen Activator
PMC3861863
24193034
Ventricular extension of intracerebral hemorrhage during intravenous thrombolysis
2013